The Society for Immunotherapy of Cancer (SITC) hosted the "Primer on Tumor Immunology and Cancer Immunotherapy™" during the SITC 2019 Annual Meeting on November 7, 2019. Available here are the presentation slides from "Session 3: Analysis of Resistance and Response" (video to follow).Program SummaryThe understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer.Program Organizers
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: SITC 34th Annual Meeting; Primer on Tumor Immunology and Cancer Immunotherapy™: Session 3: Analysis of Resistance and Response; Presenter: Julie R. Brahmer, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Date: November 7, 201900:21:15
Meeting: SITC 34th Annual Meeting; Primer on Tumor Immunology and Cancer Immunotherapy™: Session 3: Analysis of Resistance and Response; Presenter: Julie R. Brahmer, MD – Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Date: November 7, 201900:34:12
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us